Sarepta Therapeutics, INC. (SRPT) SEC Filings — 2025

Filings

• Sarepta Therapeutics, INC. 8-K Filing — 8-K · Dec 19, 2025
• Sarepta Therapeutics Files 8-K on Equity Sales — 8-K · Dec 11, 2025
• Sarepta Therapeutics Files 8-K: Director Changes & Compensation Updates — 8-K · Dec 8, 2025
• Sarepta Swings to Q3 Loss Amid ELEVIDYS Safety Concerns — 10-Q · Nov 6, 2025
• Sarepta Therapeutics, INC. 8-K Filing — 8-K · Nov 3, 2025
• Sarepta Therapeutics Enters Material Agreement — 8-K · Aug 29, 2025
• Sarepta Therapeutics Reports Unregistered Equity Sales — 8-K · Aug 21, 2025
• Sarepta Therapeutics Announces Executive and Director Changes — 8-K · Aug 13, 2025
• Sarepta's ELEVIDYS Fuels Revenue Surge, Narrows Q2 Loss — 10-Q · Aug 6, 2025
• Sarepta Therapeutics Files 8-K Report — 8-K · Jul 21, 2025
• Sarepta Acquires Roche's DMD Assets for $1.1B — 8-K · Jul 16, 2025
• Sarepta Therapeutics Announces Board and Compensation Changes — 8-K · Jun 6, 2025
• Sarepta Therapeutics Files Q1 2025 10-Q — 10-Q · May 6, 2025
• Sarepta Therapeutics Files DEF 14A on Executive Compensation — DEF 14A · Apr 24, 2025
• Sarepta Therapeutics Files 2024 10-K — 10-K · Feb 28, 2025
• Sarepta Therapeutics Files 8-K on Financials — 8-K · Feb 26, 2025
• Sarepta Therapeutics Enters Material Definitive Agreement — 8-K · Feb 14, 2025
• Sarepta Therapeutics Files 8-K on Financials — 8-K · Jan 13, 2025